177 related articles for article (PubMed ID: 10918166)
1. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes.
Greenberg DB; Jonasch E; Gadd MA; Ryan BF; Everett JR; Sober AJ; Mihm MA; Tanabe KK; Ott M; Haluska FG
Cancer; 2000 Jul; 89(2):356-62. PubMed ID: 10918166
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin in the acute treatment of refractory bipolar disorder.
Altshuler LL; Keck PE; McElroy SL; Suppes T; Brown ES; Denicoff K; Frye M; Gitlin M; Hwang S; Goodman R; Leverich G; Nolen W; Kupka R; Post R
Bipolar Disord; 1999 Sep; 1(1):61-5. PubMed ID: 11256659
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric complications associated with interferon - alpha -2b treatment of malignant melanoma.
Enudi W; Udolu OJ
Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):227-8. PubMed ID: 19750253
[TBL] [Abstract][Full Text] [Related]
4. Mania associated with interferon alpha2b treatment.
Basanth KK; Jacob R; Jacob KS
J Postgrad Med; 2006; 52(3):207-9. PubMed ID: 16855324
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin as prophylaxis against steroid-induced mania.
Ginsberg DL; Sussman N
Can J Psychiatry; 2001 Jun; 46(5):455-6. PubMed ID: 11441792
[No Abstract] [Full Text] [Related]
6. [Gabapentin in the treatment of mania].
Grunze H; Erfurth A; Amann B; Normann C; Walden J
Fortschr Neurol Psychiatr; 1999 Jun; 67(6):256-60. PubMed ID: 10399045
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin in the treatment of adolescent mania: a case report.
Soutullo CA; Casuto LS; Keck PE
J Child Adolesc Psychopharmacol; 1998; 8(1):81-5. PubMed ID: 9639083
[TBL] [Abstract][Full Text] [Related]
8. An open label study of gabapentin in the treatment of acute mania.
Erfurth A; Kammerer C; Grunze H; Normann C; Walden J
J Psychiatr Res; 1998; 32(5):261-4. PubMed ID: 9789203
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states.
Perugi G; Toni C; Ruffolo G; Sartini S; Simonini E; Akiskal H
Pharmacopsychiatry; 1999 Jul; 32(4):136-41. PubMed ID: 10505483
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin in geriatric mania.
Sethi MA; Mehta R; Devanand DP
J Geriatr Psychiatry Neurol; 2003 Jun; 16(2):117-20. PubMed ID: 12807075
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin treatment for bipolar disorders.
Maidment ID
Ann Pharmacother; 2001 Oct; 35(10):1264-9. PubMed ID: 11675857
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS
J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of gabapentin in bipolar spectrum disorders.
Carta MG; Hardoy MC; Hardoy MJ; Grunze H; Carpiniello B
J Affect Disord; 2003 Jun; 75(1):83-91. PubMed ID: 12781355
[TBL] [Abstract][Full Text] [Related]
14. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
15. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders.
Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R
Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin augmentation therapy in bipolar depression.
Wang PW; Santosa C; Schumacher M; Winsberg ME; Strong C; Ketter TA
Bipolar Disord; 2002 Oct; 4(5):296-301. PubMed ID: 12479661
[TBL] [Abstract][Full Text] [Related]
18. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
[TBL] [Abstract][Full Text] [Related]
19. Patient preferences for adjuvant interferon alfa-2b treatment.
Kilbridge KL; Weeks JC; Sober AJ; Haluska FG; Slingluff CL; Atkins MB; Sock DE; Kirkwood JM; Nease RF
J Clin Oncol; 2001 Feb; 19(3):812-23. PubMed ID: 11157035
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series.
Ghaemi SN; Goodwin FK
J Affect Disord; 2001 Jul; 65(2):167-71. PubMed ID: 11356240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
